Table 2. Age, HPV-31 type and final pathologic result.
|
Features |
Mean ± SD |
Median (range) |
|
|
Age |
44.4±9.24 |
42 (28-66) |
|
|
- |
n |
% |
|
|
HPV-31 |
Isolated HPV-31 |
69 |
53.1 |
|
Combined HPV-31 |
61 |
46.9 |
|
|
HPV-31 and other HPV type |
HPV-16 |
7 |
11.4 |
|
HPV-18 |
8 |
13.1 |
|
|
HPV-33 |
5 |
8.2 |
|
|
HPV-35 |
9 |
14.7 |
|
|
HPV-39 |
7 |
11.4 |
|
|
HPV-45 |
5 |
8.2 |
|
|
HPV-51 |
12 |
19.7 |
|
|
HPV-52 |
8 |
13.1 |
|
|
HPV-56 |
10 |
16.4 |
|
|
HPV-58 |
5 |
8.2 |
|
|
HPV-59 |
3 |
4.9 |
|
|
HPV-68 |
4 |
6.5 |
|
|
Final pathologic results |
Benign |
68 |
52.3 |
|
LSIL |
53 |
40.8 |
|
|
HSIL (CIN 2) |
5 |
3.8 |
|
|
HSIL (CIN 3) |
3 |
2.3 |
|
|
Cancer |
1 |
0.8 |
|
HPV: Human papillomavirus, LSIL: Low grade squamous intraepithelial lesion, HSIL: High grade squamous intraepithelial lesion, CIN: Cervical intraepithelial neoplasia, SD: Standard deviation